IFN-gamma mediates the death of Th1 cells in a paracrine manner

The Journal of Immunology : Official Journal of the American Association of Immunologists
Kathryn E FouldsChang-You Wu

Abstract

Th1 cells have different capacities to develop into memory cells based on their production of IFN-gamma. In this study, the mechanism by which a homogenous population of IFN-gamma-producing CD4 T cells was eliminated in vivo was assessed. When such cells were transferred into naive mice and activated with Ag, a striking decrease in the frequency of cells in the spleen and lung was observed. However, administration of neutralizing anti-IFN-gamma Ab at the time of Ag challenge largely prevented the elimination of such cells. To determine whether IFN-gamma was mediating its effects directly and/or indirectly, the ability of IFN-gamma to effectively signal in such cells was assessed in vitro. Indeed, there was reduced phosphorylation of STAT1 in response to IFN-gamma as well as markedly reduced expression of the IFN-gammaR beta-chain. Furthermore, transfer of such cells into IFN-gammaR-deficient mice limited their death following activation with Ag. Together, these data suggest that IFN-gamma acts in a paracrine manner to mediate the death of activated IFN-gamma-producing Th1 cells. In contrast to Ag stimulation, administration of CpG alone resulted in the elimination of Th1 cells in IFN-gammaR-/- mice. These results show that in r...Continue Reading

References

Jan 1, 1996·The Journal of Experimental Medicine·X MaG Trinchieri
Oct 4, 1996·Science·L H Boise, C B Thompson
Jan 1, 1997·Annual Review of Immunology·E A BachR D Schreiber
Mar 10, 2001·Nature·R L ReinhardtM K Jenkins
Sep 29, 2001·Nature Immunology·C Bogdan
Apr 3, 2002·The Journal of Experimental Medicine·Huji XuMichael F Good
Apr 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Nobuki HayashiWilliam E Paul
Sep 17, 2002·Cell Death and Differentiation·F FallarinoP Puccetti
Oct 9, 2002·The Journal of Experimental Medicine·Eulogia RománSusan L Swain
Oct 9, 2002·The Journal of Experimental Medicine·Yosef RefaeliAbul K Abbas
Mar 18, 2003·Nature Immunology·Amanda V GettJens Geginat
Sep 24, 2004·Nature·Roberto A MaldonadoLaurie H Glimcher
Oct 2, 2004·Nature Reviews. Immunology·Andrew L Mellor, David H Munn
Oct 21, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jason K WhitmireJ Lindsay Whitton
Nov 16, 2005·Nature Immunology·Chen ZhuVijay K Kuchroo
Feb 24, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Markus FeuererJochen Huehn
Jul 11, 2006·Immunological Reviews·Kathryn E FouldsRobert A Seder

❮ Previous
Next ❯

Citations

Mar 21, 2008·Blood·Pawel MuranskiNicholas P Restifo
Jul 20, 2010·Immunological Reviews·K Kai McKinstrySusan L Swain
Feb 1, 2012·Clinical and Experimental Immunology·A B B MacedoP M De Luca
Sep 3, 2011·American Journal of Reproductive Immunology : AJRI·Alexandre U BorbelyEstela Bevilacqua
Jul 3, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·F Betul GulogluHabib Zaghouani
Dec 2, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·David CarettoAbul K Abbas
Dec 30, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xiongfei XuXuetao Cao
Dec 3, 2010·PLoS Pathogens·Robin Stephens, Jean Langhorne
Sep 2, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ana Villegas-MendezKevin N Couper
Nov 26, 2010·Journal of Neurology·Ming-Ou Lu, Jie Zhu
Oct 13, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Horng-Ren YangShiguang Qian
Jun 23, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kazuyuki NakagomeMakoto Dohi
Jun 30, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·David C GondekMichael N Starnbach

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.